{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:59:49Z","timestamp":1790135989931,"version":"4.0.1"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.2169\/internalmedicine.0481-17","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T18:30:09Z","timestamp":1526581809000},"page":"2865-2871","source":"Crossref","is-referenced-by-count":6,"title":["A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign"],"prefix":"10.2169","volume":"57","author":[{"given":"Hisao","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Medicine, Aichi-Gakuin University School of Pharmacy, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyoshi","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yokkaichi Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Urawa","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Ise Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ise Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Hamaoka","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Ise Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Ise Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Ise Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ise Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Aichi-Gakuin University School of Pharmacy, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Aichi-Gakuin University School of Pharmacy, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Aichi-Gakuin University School of Pharmacy, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med 45: 1107-1111, 2006.","DOI":"10.2169\/internalmedicine.45.1876"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pietrangelo A. Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin. Gastroenterology 149: 1240-1251, 2015.","DOI":"10.1053\/j.gastro.2015.06.045"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kawabata H. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. Int J Hematology 107: 31-43, 2018.","DOI":"10.1007\/s12185-017-2365-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the FPN (SLC11A3) gene. J Clin Invest 108: 619-623, 2001.","DOI":"10.1172\/JCI200113468"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213-214, 2001.","DOI":"10.1038\/90038"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788, 2003.","DOI":"10.1182\/blood-2003-03-0672"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to FPN and inducing its internalization. Science 306: 2090-2093, 2004.","DOI":"10.1126\/science.1104742"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Drakesmith H, Schimanski LM, Ormerod E, at al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106: 1092-1097, 2005.","DOI":"10.1182\/blood-2005-02-0561"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hattori A, Miyajima H, Tomosugi N, et al. Clinicopathological study of Japanese patients with genetic iron overload syndromes. Pathol Int 62: 612-618, 2012.","DOI":"10.1111\/j.1440-1827.2012.02848.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Letocart E, Le Gac G, Majore S, et al. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases. Br J Haematol 147: 379-385, 2009.","DOI":"10.1111\/j.1365-2141.2009.07834.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pietrangelo A. Ferroportin disease: pathogenesis, diagnosis and treatment.. Haematologica 102: 1972-1984, 2017.","DOI":"10.3324\/haematol.2017.170720"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Liu W, Shimomura S, Imanishi H, et al. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene. Intern Med 44: 285-289, 2005.","DOI":"10.2169\/internalmedicine.44.285"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yamashita T, Morotomi N, Sohda T, et al. A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B. Clin J Gastroenterol 7: 260-264, 2014.","DOI":"10.1007\/s12328-014-0487-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Koyama C, Wakusawa S, Hayashi H, et al. A Japanese family with FPD caused by a novel mutation of <i>SLC40A1<\/i> gene: hyperferritinemia associated with a relatively low transferring saturation of iron. Intern Med 44: 990-993, 2005.","DOI":"10.2169\/internalmedicine.44.990"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography\/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 21: 4033-4038, 2007.","DOI":"10.1002\/rcm.3319"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kaneko Y, Miyajima H, Piperno A, et al. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol 45: 1163-1171, 2010.","DOI":"10.1007\/s00535-010-0259-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Unal S, Piperno A, Gumruk F. Iron chelation with deferasirox in a patient with de-novo ferroportin mutation. J Trace Elem Med Biol 30: 1-3, 2015.","DOI":"10.1016\/j.jtemb.2015.01.002"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 70: 1614-1619, 2008.","DOI":"10.1212\/01.wnl.0000310985.40011.d6"},{"key":"19","unstructured":"19. Ito H. Evidences from J-EDIT for diabetes mellitus in the elderly. Nihon Rinsho 71: 1923-1931, 2013 (in Japanese, Abstract in English)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sohda T, Okubo R, Kamimura S, Ohkawara T. Hemochromatosis with HFE gene mutation in a Japanese patient. Am J Gastroenterol 96: 2487-2488, 2001.","DOI":"10.1111\/j.1572-0241.2001.04058.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Takano A, Niimi H, Atarashi Y, et al. A novel Y231del mutation of HFE in hereditary haemochromatosis provides in vivo evidence that the Huh-7 is a human haemochromatotic cell line. Liver Int 31: 1593-1597, 2011.","DOI":"10.1111\/j.1478-3231.2011.02620.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9: 267-272, 1995.","DOI":"10.1038\/ng0395-267"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. McNeill A, Pandolfo M, Kuhn J, Shang H, Miyajima H. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 60: 200-205, 2008.","DOI":"10.1159\/000148691"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Le Lan C, Mosser A, Ropert M, et al. Sex and acquired cofactors determine phenotypes of ferroportin disease. Gastroenterology 140: 1199-1207, 2011.","DOI":"10.1053\/j.gastro.2010.12.049"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mayr R, Janecke AR, Schranz M, et al. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol 53: 941-949, 2010.","DOI":"10.1016\/j.jhep.2010.05.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Griffiths WJ, Mayr R, McFarlane I, et al. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation. Hepatology 51: 788-795, 2010.","DOI":"10.1002\/hep.23377"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/19\/57_0481-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T00:40:15Z","timestamp":1538786415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/19\/57_0481-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":26,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0481-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}